- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3189
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment ; volume:20 ; number:7 ; day:19 ; month:6 ; year:2018 ; pages:1-14 ; date:7.2018
Current treatment options in cardiovascular medicine ; 20, Heft 7 (19.6.2018), 1-14, 7.2018
- Urheber
-
Tan, Li-Ling
- Beteiligte Personen und Organisationen
-
Lyon, Alexander R.
SpringerLink (Online service)
- DOI
-
10.1007/s11936-018-0641-z
- URN
-
urn:nbn:de:101:1-2018092418523356928530
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:40 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tan, Li-Ling
- Lyon, Alexander R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
Cardiotoxicity—current recommendations of prevention and treatment
Treatment of local anaesthetic induced cardiotoxicity with lipid infusion
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Prediction of epileptogenesis by multimodal biomarkers
Metabolic Aspects of Anthracycline Cardiotoxicity
Role of metabolites of cyclophosphamide in cardiotoxicity
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
Cardiotoxicity—current recommendations of prevention and treatment
Treatment of local anaesthetic induced cardiotoxicity with lipid infusion
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Prediction of epileptogenesis by multimodal biomarkers
Metabolic Aspects of Anthracycline Cardiotoxicity
Role of metabolites of cyclophosphamide in cardiotoxicity
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
Cardiotoxicity—current recommendations of prevention and treatment
Treatment of local anaesthetic induced cardiotoxicity with lipid infusion
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Prediction of epileptogenesis by multimodal biomarkers
Metabolic Aspects of Anthracycline Cardiotoxicity